About Zylox-Tonbridge
Zylox-Tonbridge is a company based in Hangzhou (China) founded in 2012. Zylox-Tonbridge has completed 1 acquisition, including Optimed. Zylox-Tonbridge offers products and services including Neuro Vascular Devices and Patient Education Services.
- Headquarter Hangzhou, China
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zylox-Tonbridge Medical Technology Co., Ltd. Class H
-
Annual Revenue
$109.24 M (USD)45.48as on Dec 31, 2024
-
Net Profit
$14 M (USD)0as on Dec 31, 2024
-
EBITDA
$14.13 M (USD)0as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zylox-Tonbridge
Zylox-Tonbridge is a publicly listed company on the HKEX with ticker symbol 2190 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zylox-Tonbridge
Zylox-Tonbridge offers a comprehensive portfolio of products and services, including Neuro Vascular Devices and Patient Education Services.
Revascularization devices are provided for neuro vascular applications to assist in patient care.
Information about conditions and therapies is offered to patients and caregivers to enhance understanding.
Funding Insights of Zylox-Tonbridge
Detailed funding history for Zylox-Tonbridge
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zylox-Tonbridge
Zylox-Tonbridge has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Optimed.
Investment portfolio details for Zylox-Tonbridge
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of invasive therapy devices for vascular interventions, gastroenterology and urology
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for Zylox-Tonbridge
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Zylox-Tonbridge
Detailed financials for Zylox-Tonbridge
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zylox-Tonbridge Comparisons
Peer comparison for Zylox-Tonbridge
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zylox-Tonbridge
Detailed competitors of Zylox-Tonbridge
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zylox-Tonbridge
Complete news archive for Zylox-Tonbridge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zylox-Tonbridge
Zylox-Tonbridge was founded in 2012.
Zylox-Tonbridge is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Zhong Zhao is the current CEO of Zylox-Tonbridge.
Annual revenue of Zylox-Tonbridge is $109.24M as on Dec 31, 2024.
Zylox-Tonbridge was established in 2012 and is based in Hangzhou, China. Operations focus on the production of medical equipment within the healthcare sector. Devices and tools are developed and assembled at facilities in China, serving regional and international markets. Leadership is provided by CEO Zhong Zhao, overseeing manufacturing and distribution activities.
Zylox-Tonbridge offers Neuro Vascular Devices and Patient Education Services.
Yes, Zylox-Tonbridge is publicly traded on HKEX under the ticker symbol 2190.
Zylox-Tonbridge has made 1 acquisition, including Optimed.
The ticker symbol of Zylox-Tonbridge is 2190 on HKEX.